|
1
|
Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA. Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies. Cancer 2015; 121:997-1007. [DOI: 10.1002/cncr.28935] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
Affiliation(s)
- Kathryn M. Field
- Department of Medical Oncology; Royal Melbourne Hospital; Melbourne Victoria Australia
| | - Justin T. Jordan
- Center for Neuro-Oncology; Dana-Farber Cancer Institute; Boston Massachusetts
| | - Patrick Y. Wen
- Center for Neuro-Oncology; Dana-Farber Cancer Institute; Boston Massachusetts
| | - Mark A. Rosenthal
- Department of Medical Oncology; Royal Melbourne Hospital; Melbourne Victoria Australia
| | - David A. Reardon
- Center for Neuro-Oncology; Dana-Farber Cancer Institute; Boston Massachusetts
| |
Collapse
|
|
2
|
Abstract
ASCO 2014 Annual Meeting Chicago, IL, USA, 30 May–3 June 2014 ASCO, the American Society of Clinical Oncology, is the largest clinical oncology meeting in the USA that meets annually and is a venue at which new cancer clinical trials and research data are presented. The ASCO 2014 CNS tumors section comprising 2 days of posters and oral presentations and over 100 abstracts provides an up-to-date overview of neuro-oncology, including both metastatic diseases of the CNS as well as primary brain tumors. This brief review selectively highlights presentations presented at this years meeting in an organizational manner that will hopefully provide a portrait of a large and multifaceted meeting.
Collapse
|
|
3
|
Chamberlain MC. Conference Scene: Neuro-oncology: a selected review of ASCO 2013 abstracts. CNS Oncol 2013. [DOI: 10.2217/cns.13.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
ASCO 2013 Annual Meeting, Chicago, IL, USA, 31 May–4 June 2013 The American Society of Clinical Oncology (ASCO) is the largest clinical oncology meeting in the USA that meets annually, and is an exciting forum in which new cancer clinical trials and research data are presented. The ASCO 2013 CNS tumors section comprising of 3 days of posters, oral presentations and over 100 abstracts provided a current overview of neuro-oncology, including both metastatic diseases of the CNS, as well as primary brain tumors. This brief overview selectively highlights presentations featured at this year’s meeting in a manner that will hopefully provide a portrait of a large and multifaceted meeting.
Collapse
Affiliation(s)
- Marc C Chamberlain
- Department of Neurology/Division of Neuro-Oncology, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, 825 Eastlake Avenue E, POB 19023, MS G4940, Seattle, WA98109-1023, USA
| |
Collapse
|